Westfield Capital Management Co. LP Reduces Position in Cardinal Health, Inc. $CAH

Westfield Capital Management Co. LP cut its stake in shares of Cardinal Health, Inc. (NYSE:CAH) by 47.2% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 17,831 shares of the company’s stock after selling 15,938 shares during the quarter. Westfield Capital Management Co. LP’s holdings in Cardinal Health were worth $3,664,000 as of its most recent SEC filing.

A number of other institutional investors also recently bought and sold shares of CAH. Aventura Private Wealth LLC purchased a new position in Cardinal Health during the 4th quarter worth approximately $25,000. Jones Financial Companies Lllp raised its position in Cardinal Health by 198.3% during the 1st quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock worth $27,000 after buying an additional 14,034 shares during the last quarter. JPL Wealth Management LLC purchased a new position in Cardinal Health during the 3rd quarter worth approximately $31,000. Turning Point Benefit Group Inc. purchased a new stake in Cardinal Health in the third quarter valued at $31,000. Finally, Cape Investment Advisory Inc. boosted its holdings in Cardinal Health by 61.1% in the third quarter. Cape Investment Advisory Inc. now owns 211 shares of the company’s stock valued at $33,000 after purchasing an additional 80 shares during the last quarter. 87.17% of the stock is owned by hedge funds and other institutional investors.

Cardinal Health Stock Up 2.0%

NYSE:CAH opened at $205.79 on Friday. Cardinal Health, Inc. has a 52 week low of $137.75 and a 52 week high of $233.60. The stock has a market capitalization of $48.20 billion, a PE ratio of 31.47, a price-to-earnings-growth ratio of 1.10 and a beta of 0.52. The stock’s 50-day moving average price is $202.53 and its 200-day moving average price is $208.57.

Cardinal Health (NYSE:CAH) last posted its earnings results on Thursday, April 30th. The company reported $3.17 EPS for the quarter, beating analysts’ consensus estimates of $2.79 by $0.38. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.The firm had revenue of $60.94 billion for the quarter, compared to analysts’ expectations of $62.10 billion. During the same period last year, the firm earned $2.35 EPS. The company’s quarterly revenue was up 11.0% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. Sell-side analysts expect that Cardinal Health, Inc. will post 10.76 earnings per share for the current fiscal year.

Cardinal Health Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, July 15th. Stockholders of record on Wednesday, July 1st will be given a dividend of $0.5158 per share. This is a boost from Cardinal Health’s previous quarterly dividend of $0.51. The ex-dividend date is Wednesday, July 1st. This represents a $2.06 dividend on an annualized basis and a dividend yield of 1.0%. Cardinal Health’s payout ratio is 31.19%.

Wall Street Analysts Forecast Growth

Several equities research analysts have commented on the stock. Argus upped their price target on shares of Cardinal Health from $232.00 to $248.00 and gave the company a “buy” rating in a report on Wednesday, February 11th. UBS Group set a $260.00 price target on shares of Cardinal Health and gave the company a “buy” rating in a report on Friday, February 6th. Mizuho upped their price target on shares of Cardinal Health from $222.00 to $235.00 and gave the company an “outperform” rating in a report on Friday, February 6th. Leerink Partners reaffirmed an “outperform” rating and issued a $275.00 price target on shares of Cardinal Health in a report on Monday, March 9th. Finally, JPMorgan Chase & Co. lowered their price target on shares of Cardinal Health from $243.00 to $215.00 and set a “neutral” rating on the stock in a report on Monday, May 4th. One investment analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $241.80.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.